ArticleFrontiers in cellular and infection microbiology2025
Development and validation of a nomogram-based prediction model for hospital-acquired carbapenem-resistant Acinetobacter baumannii in critically ill patients: a multicenter retrospective cohort study.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections?JAC-antimicrobial resistance · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) remains a major challenge in intensive care units (ICUs), posing substantial risks for colonization, infection, and transmission. Timely identification of patients at risk for hospital-acquired CRAB is essential to guide infection prevention and control efforts. This study aimed to develop and internally validate a nomogram for individualized risk prediction of hospital-acquired CRAB colonization or infection among critically ill patients. Methods: A retrospective multicenter cohort study was performed including 7,060 ICU patients admitted to two tertiary hospitals in China between January 1, 2019 and December 31, 2024. Candidate predictors were identified through univariate logistic regression and further refined using multivariate logistic regression with backward stepwise selection. A nomogram was subsequently constructed based on the final regression model to predict individualized risk of hospital-acquired CRAB. Model performance was evaluated in separate training and validation cohorts using area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analysis (DCA). Results: Hospital-acquired CRAB colonization or infection was observed in 224 patients (3.17%). Six independent risk factors were retained in the final model: carbapenem exposure, presence of other multidrug-resistant organisms (MDROs), mechanical ventilation, number of ICU admissions, ICU length of stay, and hospital length of stay. The nomogram exhibited strong discriminative capacity (AUC = 0.824 in the training cohort; 0.789 in the validation cohort) and demonstrated good calibration across both cohorts. DCA indicated a consistent net clinical benefit across a wide range of threshold probabilities. A risk cutoff of 0.022 (derived from the Youden index) was selected to prioritize sensitivity for infection prevention in this low-incidence setting. Conclusion: This internally validated nomogram provides an accessible tool for early identification of ICU patients at elevated risk of hospital-acquired CRAB colonization or infection. Its integration into clinical practice may facilitate risk-based prevention strategies. Future research should focus on prospective external validation and integration of environmental surveillance and microbiological genomic data to enhance the model's predictive accuracy and generalizability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.